Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan

Authors:

Abstract
Chronic hepatitis C virus (HCV) infection is a global health problem that affects 70 million people worldwide.1 It is associated with a substantial morbidity and mortality burden, and in 2015, approximately 400 000 people died of HCV infection. Pakistan has a generalized epidemic of HCV infection and one of the highest prevalence rates (4.9%) in the world, with 8 million to 11 million individuals with active HCV viremia.1,2 Furthermore, most HCV-infected individuals in Pakistan remain undiagnosed.2 Most HCV infections in Pakistan are transmitted through unsafe medical practices, especially reuse of injection equipment in the health care setting.3 In addition, people who inject drugs, although a small proportion of the population, have a high prevalence of infection, ranging from 40% to 90%.4,5

This publication has 26 references indexed in Scilit: